CHO-H02

N/A

Report date: 2024/11/05 16:40:46

Base Information

Drug NameCHO-H02
Drug Alias NameCHO-H02
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionReceptor protein-tyrosine kinase erbB-2 inhibitors
TargetsReceptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCho Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAcademia Sinica
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A